| Primary |
| Pain |
17.7% |
| Product Used For Unknown Indication |
15.5% |
| Drug Use For Unknown Indication |
14.9% |
| Pyrexia |
8.8% |
| Arthritis |
5.7% |
| Musculoskeletal Pain |
4.7% |
| Headache |
4.0% |
| Back Pain |
3.8% |
| Hypertension |
3.1% |
| Arthralgia |
3.0% |
| Migraine |
2.9% |
| Diabetes Mellitus |
2.7% |
| Depression |
2.5% |
| Rheumatoid Arthritis |
1.8% |
| Completed Suicide |
1.6% |
| Pain In Extremity |
1.6% |
| Fibromyalgia |
1.5% |
| Osteoarthritis |
1.5% |
| Influenza |
1.3% |
| Suicide Attempt |
1.2% |
|
| Product Quality Issue |
16.3% |
| Vomiting |
10.1% |
| Toxic Epidermal Necrolysis |
8.8% |
| Hypersensitivity |
7.5% |
| Weight Decreased |
6.6% |
| Gastric Ulcer |
6.2% |
| Pain |
4.4% |
| Pyrexia |
4.4% |
| Drug Ineffective |
3.5% |
| Gastric Haemorrhage |
3.5% |
| Ulcer |
3.5% |
| Haemorrhage |
3.1% |
| Suicide Attempt |
3.1% |
| Urticaria |
3.1% |
| Weight Increased |
3.1% |
| Drug Hypersensitivity |
2.6% |
| Overdose |
2.6% |
| Renal Failure |
2.6% |
| Renal Failure Acute |
2.6% |
| Gastrointestinal Haemorrhage |
2.2% |
|
| Secondary |
| Pain |
16.2% |
| Drug Use For Unknown Indication |
15.1% |
| Product Used For Unknown Indication |
11.7% |
| Pyrexia |
8.1% |
| Headache |
6.4% |
| Arthritis |
5.1% |
| Depression |
4.4% |
| Hypertension |
4.2% |
| Fibromyalgia |
3.7% |
| Rheumatoid Arthritis |
3.7% |
| Musculoskeletal Pain |
3.3% |
| Back Pain |
2.7% |
| Arthralgia |
2.4% |
| Migraine |
2.2% |
| Diabetes Mellitus |
2.2% |
| Inflammation |
2.1% |
| Ill-defined Disorder |
1.9% |
| Analgesic Therapy |
1.7% |
| Osteoarthritis |
1.6% |
| Hypersensitivity |
1.5% |
|
| Dyspepsia |
12.3% |
| Toxic Epidermal Necrolysis |
11.1% |
| Product Quality Issue |
10.2% |
| Vomiting |
10.0% |
| Weight Decreased |
7.6% |
| Drug Hypersensitivity |
7.2% |
| Drug Ineffective |
6.7% |
| Pyrexia |
3.9% |
| Pain In Extremity |
3.7% |
| Wrong Drug Administered |
3.7% |
| Suicide Attempt |
3.2% |
| Ulcer |
2.8% |
| Rash Macular |
2.5% |
| Gastric Ulcer |
2.3% |
| Pain |
2.3% |
| Weight Increased |
2.3% |
| Renal Failure Acute |
2.1% |
| Stevens-johnson Syndrome |
2.1% |
| Urticaria |
2.1% |
| Gastric Disorder |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.5% |
| Pain |
14.9% |
| Drug Use For Unknown Indication |
8.8% |
| Contraception |
7.3% |
| Hypertension |
4.8% |
| Depression |
4.5% |
| Multiple Sclerosis |
4.1% |
| Acne |
4.0% |
| Headache |
3.8% |
| Asthma |
3.7% |
| Rheumatoid Arthritis |
3.1% |
| Premenstrual Syndrome |
2.9% |
| Back Pain |
2.9% |
| Anxiety |
2.8% |
| Migraine |
2.7% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Arthritis |
2.0% |
| Premedication |
1.9% |
| Hypersensitivity |
1.7% |
| Arthralgia |
1.7% |
|
| Vomiting |
11.7% |
| Pulmonary Embolism |
11.6% |
| Pain |
11.1% |
| Deep Vein Thrombosis |
6.8% |
| Drug Ineffective |
6.3% |
| Weight Increased |
5.7% |
| Weight Decreased |
4.9% |
| Nausea |
4.2% |
| Vision Blurred |
3.7% |
| Cholelithiasis |
3.6% |
| Headache |
3.6% |
| Injury |
3.6% |
| Urinary Tract Infection |
3.3% |
| Thrombosis |
3.2% |
| Cholecystitis Chronic |
3.0% |
| Pain In Extremity |
3.0% |
| Anxiety |
3.0% |
| Withdrawal Syndrome |
2.7% |
| Myocardial Infarction |
2.6% |
| Dyspnoea |
2.4% |
|
| Interacting |
| Pain |
42.9% |
| Headache |
9.5% |
| Fall |
7.1% |
| Migraine |
4.8% |
| Product Used For Unknown Indication |
4.8% |
| Psoriasis |
4.8% |
| Bronchitis |
2.4% |
| Cardiovascular Disorder |
2.4% |
| Convulsion |
2.4% |
| Drug Use For Unknown Indication |
2.4% |
| Epilepsy |
2.4% |
| Hypertension |
2.4% |
| Ill-defined Disorder |
2.4% |
| Postoperative Analgesia |
2.4% |
| Smoking Cessation Therapy |
2.4% |
| Thrombosis Prophylaxis |
2.4% |
| Toothache |
2.4% |
|
| Drug Interaction |
27.8% |
| Headache |
11.1% |
| Therapeutic Response Decreased |
11.1% |
| Euphoric Mood |
5.6% |
| Lower Gastrointestinal Haemorrhage |
5.6% |
| Pain |
5.6% |
| Speech Disorder |
5.6% |
| Swollen Tongue |
5.6% |
| Thrombosis |
5.6% |
| Toothache |
5.6% |
| Weight Increased |
5.6% |
| Wheezing |
5.6% |
|
